TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Invex Therapeutics Ltd. ( (AU:IXC) ).
Invex Therapeutics Limited has requested a voluntary suspension of its securities from quotation on the ASX, effective immediately. This suspension is pending an upcoming announcement regarding a significant acquisition and responses to a price query from the ASX, with trading expected to resume by September 29, 2025.
More about Invex Therapeutics Ltd.
Invex Therapeutics Limited operates in the biotechnology sector, focusing on developing innovative therapies for neurological conditions. The company is primarily engaged in research and development activities aimed at addressing unmet medical needs in the market.
Average Trading Volume: 65,890
Technical Sentiment Signal: Buy
Current Market Cap: A$11.65M
Find detailed analytics on IXC stock on TipRanks’ Stock Analysis page.